70
Views
1
CrossRef citations to date
0
Altmetric
Correspondence

Is measuring plasma imatinib trough levels still an appropriate way for predicting responses in patients with chronic myeloid leukemia?

ORCID Icon
Pages 2094-2095 | Received 06 Nov 2018, Accepted 07 Jan 2019, Published online: 04 Feb 2019
 

Acknowledgements

AEE would like to thank Prof. Hasan Yazici for his continuous support and guidance especially during his internal medicine residency.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1571202.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.